The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Heyrman Reinilde since 2015.
The trader's CIK number is 1630929.
At the time of the last reporting, Heyrman Reinilde was the Chief Clinical Dev. Officer of Bellerophon Therapeutics, Inc.. (stock ticker symbol BLPH).
Also see all insider trading activities at Bellerophon Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | BLPH | 1,500 | $18,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-02-19 | BLPH | Buy | 1,500 | 12.00 | 18,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Heyrman Reinilde (Chief Clinical Dev. Officer of Bellerophon Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.